Cosmos Health signs five-year Viofar manufacturing deal for 2.5 million ROSARTIA units - COSM News | RalliesCosmos Health signs five-year Viofar manufacturing deal for 2.5 million ROSARTIA units
C
COSM• Five-year manufacturing agreement with Viofar
- Cosmos Health signed a five-year contract manufacturing agreement with Viofar for about 2,500,000 units of ROSARTIA.
- Annual contracted volume set at roughly 500,000 units across multiple strengths of the rosuvastatin-based statin therapy.
- Cumulative contract manufacturing orderbook rose above 27,500,000 units, up from more than 25,000,000 units reported in June 2026.
•
